Search for: "Takeda Global Research "
Results 21 - 39
of 39
Sorted by Relevance
|
Sort by Date
9 Dec 2009, 3:59 pm
(Patent Docs) Rozerem (Ramelteon) – US: Complaint filed in Delaware: Infringement of US patent following a Paragraph IV challenge: Takeda Pharmaceutical Co. [read post]
24 Feb 2010, 2:11 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW)… [read post]
24 Feb 2010, 2:11 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW)… [read post]
13 Jun 2008, 3:40 am
, (IPKat), (IPKat), (Class 46), (IPKat), (IP Law360), Quanta – Supreme Court reverses CAFC decision in Quanta v LG Electronics; method patents exhaustible: (Peter Zura's 271 Patent Blog), (IP Updates), (Hal Wegner), (Patently-O), (Techdirt), (Patent Prospector), (Ars Technica), (Patent Docs), (Agricultural Law Blog), (Filewrapper), (Intellectual Property Law Blog), (Philip Brooks), (Philip Brooks guest blog), (IP ThinkTank), (Electronic Frontier Foundation), (IAM), (IAM), (IPBiz),… [read post]
30 Nov 2017, 5:47 pm
§ 355(c)(3)(C), (j)(5)(B)(iii).from Takeda, 78 F. [read post]
1 Dec 2017, 11:35 am
Two oncology drugs, Iclusig and Brigatinib, will enhance Takeda’s position in hematology. [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360) … [read post]
19 Oct 2010, 10:42 pm
Honeywell (Patents Post-Grant) (IPBiz) (Patently-O) US: ‘At home’ testing for BRCA gene mutations (Patent Docs) US: New draft guidance for industry: INDs – determining whether human research studies can be conducted without an IND (FDA Law Blog) US: Patent extensions: some academic perspectives? [read post]
15 Aug 2012, 11:02 am
(“Watson”), involves generic versions of Takeda Global Research & Development Center, Inc. [read post]
26 Aug 2019, 12:09 pm
Daimler: (anti-)anti suit injunctions and the Brussels I regime in global FRAND litigation | Are FRAND-disputes too complex for PI proceedings? [read post]
12 Apr 2011, 10:07 pm
General Open Access database of key HIV patents launched by medicines patent pool (IP Watch) Information challenges for product, process development and process design: a reality check (profitability through simplicity) ‘The price of innovation’: Report suggests that the cost of drug R&D is inflated (IP Osgoode) Preparing the world for influenza pandemic, industry role key, says WHO (IP Watch) Australia: Budget cuts threaten Australian medical research funding (Patentology)… [read post]
31 May 2011, 8:38 pm
– response to OPPI vice chairman’s interview with the Financial Express (Spicy IP) Japan: IP High Court guidance on availability of patent term extension for new forms of previously approved medicine (The SPC Blog) Japan – IP High Court offers guidance on patent term extension for combination of known drugs (The SPC Blog) Switzerland – The Swiss Federal Supreme Court approves new dosage regime as patentable subject matter in Swiss Type Claims under the EPC 1973 – Merck… [read post]
26 Jan 2010, 7:06 am
29.01.2010 A Global Solution to Illicit Trade? [read post]
13 Aug 2019, 6:03 am
: Copyright and the Court of Justice of the European Union | South African IP researchers’ (AIPLITL) conference report – The IP and IT Law Innovation Interface | Event report - Second IP Researchers Europe Conference in Geneva | Why is there less innovation? [read post]
28 Apr 2008, 11:00 am
: (Techdirt), A day in the life of an IP blog – WIPO magazine article about the blogging life of Jeremy Phillips: (Patent Baristas) Global - Trade Marks / Domain Names / Brands Droste effect packaging: (box vox), (Class 46), Against cyberproperty (and cybertrespass): (The Trademark Blog), Fabergé egg flip – Article on Fabergé brand and protection strategy: (Afro-IP), Domain name tasting proposal passed by… [read post]
29 Dec 2010, 2:57 am
(Patent Docs) US: Fred Hutchinson Cancer Research Center files patent infringement complaints against MMI Genomics and Biopet Vet based on their dog breed identification services (Patent Docs) Products Actonel (Risedronate) – US: Warner Chilcott files patent infringement complaint against Apotex following Para IV certification filing (Patent Docs) Actos (Pioglitazone), Actoplus (Pioglitazone, Metformin) – US: Teva settles patent litigation with Takeda (The IP Factor)… [read post]
26 Apr 2021, 7:42 am
Manufacturing partnerships on a global scale are cumbersome. [read post]
16 Mar 2021, 6:00 am
See, e.g., Takeda Pharm. [read post]
30 Jan 2024, 9:31 pm
JYPIL is a peer-reviewed journal that presents trends in academic research in the field of private international law in Japan, with high-quality discussion of the most important issues in the field from both Japanese and comparative law perspectives. [read post]
